MC Services AG

🩷 💙💚 90% of rare diseases have no approved therapies.  Over 300 million people suffer from more than 7,000 identified rare diseases. Every road to diagnosis and care can represent a long and challenging journey for patients and their families. Today is Rare Disease Day: On the last day of February every year, this global movement unites patients, healthcare professionals, and advocates to drive progress in research, policy, and treatments. At MC Services, we are proud to support organizations and clients dedicated to advancing solutions. Companies like InflaRx, working on pyoderma gangrenosum, and DEBRA Research, focused on epidermolysis bullosa, are striving to bring hope and therapies to those in need. 🔹 Join the movement! Across Germany, many activities are bringing rare diseases into focus - In Munich, we stopped by the #colourUp4RARE event in the city center, where a life-sized zebra is being colored in - representing the uniqueness of all rare disease patients everywhere. Find an event near you: https://lnkd.in/g_Qhh2ub #RareDiseaseDay #ShowYourRare #LightUpForRare  

💡 AI Breakthrough Brings New Hope to AFib Patients 🫀 Living with Atrial Fibrillation (AFib) can be challenging, but a new study published in Nature Medicine offers real hope.  AI-guided cardiac ablation has been shown to outperform the current standard treatment for Persistent AFib, leading to better outcomes for patients. A big congratulations to Théophile Mohr Durdez, Deisenhofer Isabel and the entire Volta Medical team for this groundbreaking achievement!🎉 By helping doctors precisely target problem areas in the heart, their AI technology is making ablation procedures more effective and personalized than ever before. 🤖💡 For patients, this could mean fewer procedures, better results, and an improved quality of life. 💪❤️ Curious to learn more? 📖 Dive into the full study and see how AI is changing the future of heart care. 👉 https://lnkd.in/eUPZSizH 💬 What are your thoughts on AI transforming healthcare? Share below! ⬇ 

Zurich is calling! Katja Arnold will be attending this year’s Sachs Associates European Life Sciences CEO Forum, supporting our clients, and engaging in discussions on biotech investments, partnerships, and industry developments.   Some panel highlights are:    🧠 Advances in the Treatment of Neurological Disorders panel 📅Wednesday, 26th February, 17:00 CET with Alexander Gebauer, Co-founder and Executive Chairman of Galimedix Therapeutics, Inc.   💰 Pharma Dealmakers Panel 📅 Thursday, 27th of February, 08:50 CET, with Konstantin Petropoulos, CEO & Managing Director of Secarna Pharmaceuticals GmbH & Co. KG   💊Cancer Progress Panel Thursday, 27th of February, 13:10 CET with Andreas Pahl, CEO of Heidelberg Pharma AG, and Peter Llewellyn-Davies, CEO &CFO of invIOs INNOVATIVE IMMUNO-ONCOLOGY   📢 Company Presentations: Discover the latest advancements from AATec Medical, ActiTrexx GmbH, ARTCLINE GmbH, Galimedix Therapeutics, Inc., and iOmx Therapeutics AG on site!   Don’t miss the opportunity to connect with Katja in Zurich.   #Sachs_ELSF #SachsForum #Biotech #LifeSciences #PharmaInvesments #HealthcareInvestment

  After a successful year as a trainee at MC Services AG, we are delighted to have Luis A. Rodríguez C., Ph.D.  with us as a junior consultant and congratulate him on the well-deserved promotion. 🎉   With a strong background in Life Sciences and Biology, Luis holds a Master’s degree in Regenerative Biology and Medicine from TU Dresden and a PhD in pediatric medicine from the University Hospital/TU Dresden. 🧬 His responsibilities include corporate materials, newsflow, and client communication while he is also experienced in developing structured social media strategies. As a native Spanish speaker, Luis also monitors Spanish-speaking media. We look forward to seeing his continued success and contributions in this role. Congratulations, Luis! 🎉   #Promotion #NewRole #LifeSciences #Consulting #Biology #ScienceCommunication

We're thrilled that our own Catherine Featherston will be sharing her media expertise at LSI USA ‘25! Dive into strategies to break through the noise and secure impactful media attention.   📌 Learn how to: ✔ Craft compelling stories that resonate with journalists ✔ Build strong media relationships ✔ Navigate the evolving news landscape   Don’t miss this opportunity to gain actionable insights that can elevate your company’s visibility. See you there!   #LSIUSA2025 #MedTech #HealthTech #MediaRelations #PublicRelations #InvestorRelations #Storytelling

Meet us at #LSIUSA25 Emerging Medtech Summit March 17–21, 2025, in Dana Point, California! 🌊☀️   At the epicenter of medtech, the LSI USA '25 summit will bring together executives, innovators, and investors from the medtech and healthtech sectors to discuss emerging trends, challenges and opportunities. 💡🔬   🎤 With keynotes from industry leaders like Gary Guthart (Intuitive) and Lisa Earnhardt (Abbott), and sessions on AI, robotics, and cardiovascular investments, it’s shaping up to be a thought-provoking event!   📢 MC Services is proud to support the summit as media partner, and our colleagues Catherine Featherston and Laurie Doyle will be onsite to facilitate media engagements and support our clients.   📍 Learn more about the event: https://lnkd.in/dw_teTUK   Stay tuned for updates, behind-the-scenes moments, and highlights from the summit!     #LSIUSA2025 #MedTech #Innovation #HealthTech #AIinHealthcare #Robotics #MedicalTechnology #MedTechInvestment #HealthcareInnovation #FutureofMedTech #Networking #EmergingTech

 🧬 On World Cancer Day, we reflect on the collective efforts to combat cancer and highlight the progress being made. This year’s theme, #UnitedByUnique reminds us of the importance of addressing the needs of patients and the critical role developing new treatments. 🤝 At MC Services, we are proud to support innovative companies dedicated to transforming the oncology landscape.   In immuno-oncology, invIOs INNOVATIVE IMMUNO-ONCOLOGY is advancing cell therapies and small molecules to activate the immune system against solid tumors, like glioblastoma, while iOmx Therapeutics AG focuses on ‘modality-open’ approaches and unexplored immune evasion mechanisms in multiple solid tumors.   Medigene AG is developing TCR-based T-cell engagers targeting neoantigens, including KRAS mutations, in challenging cancer types like pancreatic and lung cancer.  Lindis Biotech GmbH utilizes its Triomab® antibody platform to activate T-cells for targeted cancer therapies, while ActiTrexx GmbH develops Actileucel, a novel therapy of activated regulatory T-cells, to prevent graft-versus-host disease in leukemia patients.   QUANTRO Therapeutics GmbH enables time-resolved transcriptomic profiling to target cancer-associated transcription factors previously considered undruggable and Heidelberg Pharma AG develops antibody-drug conjugates (ADCs) based on novel and potent payloads such as Amanitin against a variety of cancers.  Lindis Blood Care GmbH is enhancing the safety of cancer surgeries with CATUVAB®, and Formycon AG is developing a Keytruda biosimilar candidate to make effective biologic therapies more affordable and accessible for patients worldwide. They are united in finding new treatments for patients. #UnitedByUnique.  #WorldCancerDay #Oncology #LifeSciences  Union for International Cancer Control (UICC)

Last week, we had the honor of hosting BIOTECH AUSTRIA’s 17th CEO Lunch at the Vienna BioCenter!  The event was a great opportunity to connect with industry leaders and discuss how biotech companies can build reputation, awareness, and make meaningful connections.   With BIO-Europe 2025 coming to Vienna this November, strategies to maximize visibility at industry events, including social media, digital outreach, media activities, and effective partnering, are more relevant than ever for Austrian biotech companies looking to make an impact on the global stage. 🌍 We thank BIOTECH AUSTRIA and all participants joining us for insightful discussions and networking over lunch and coffee. It’s inspiring to be part of this dynamic community and we look forward to continuing our support of the Austrian biotech scene. Interested in discussing your conference preparation for BIO-Europe Milan, Vienna (and beyond)? Reach out to Dr. Cora Kaiser and Johanna Kobler! #BiotechAustria #LifeSciences #BIOEurope2025

“One in eight women in Germany is diagnosed with breast cancer, and more and more young women are affected…But novel drugs give hope.” Read more about the remarkable progress being made in breast cancer research and treatment—progress that is giving hope to millions of patients worldwide. Check out the latest insightful article from Theresa Rauffmann at Handelsblatt highlighting the three latest advancements that are promising to transform breast cancer treatment and detection, and showing how far medical science has come in personalizing care and improving outcomes. (German language and paywall).

🎉 Celebrating 10 Wonderful Years with Petra Hegmann at MC Services! 🎉 For the past decade, our Executive Assistant Petra has been the backbone of our Düsseldorf office, combining her incredible organizational talent with a thoughtful approach to executive support and office management. With over 20 years of professional experience, including a degree in Business Administration from the University of Köln, Petra ensures everything runs smoothly with her ability to handle the complexity of coordinating our international teams with calm precision. Petra’s dedication, attention to detail, and warm personality make her an invaluable part of MC Services. Thank you, Petra, for your unwavering commitment and the many ways you make a difference every day. Here's to many more years of collaboration, shared achievements, and moments of joy! 🥂